ARCHIVES

NIH Defines Misconduct

This article is from The Cancer Letter archive.

Vol. 20 No. 47 | December 9, 1994

Download PDF Visit The Full Archive

Related Articles

Basic Research Group Seeks $7.9 Billion For NIH, $1.7 For NCI

July 24, 1987

UK’s NICE Set to Deny Payments For Zaltrap In Second-Line Metastatic Colorectal Cancer

June 26, 2013

NCI-DOD Agreement Could Be Model For Similar Project With HCFA, Lee Says

March 8, 1996

Genetic Testing: No Easy Answers To Public Questions

May 15, 1998

ASCO, AACR Honor Scientists, Journalists At Annual Meetings

May 29, 1992

SWOG, NCI Canada halt two large trials of Iressa for non-small cell lung cancer.

April 22, 2005